Compare GOGO & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOGO | YDES |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.2M | 543.0M |
| IPO Year | 2011 | 2024 |
| Metric | GOGO | YDES |
|---|---|---|
| Price | $2.83 | $2.57 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 30.7K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $910,491,000.00 | N/A |
| Revenue This Year | $3.68 | N/A |
| Revenue Next Year | $3.60 | N/A |
| P/E Ratio | $35.38 | ★ N/A |
| Revenue Growth | ★ 104.74 | N/A |
| 52 Week Low | $2.77 | $1.70 |
| 52 Week High | $12.50 | $25.00 |
| Indicator | GOGO | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 32.14 | 48.58 |
| Support Level | N/A | $2.14 |
| Resistance Level | $4.89 | $2.93 |
| Average True Range (ATR) | 0.28 | 0.30 |
| MACD | -0.16 | 0.06 |
| Stochastic Oscillator | 4.30 | 41.43 |
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.